DNTH (NASDAQ) director files Form 144 to sell 26,530 shares

Rhea-AI Filing Summary

DNTH filing of a Form 144 notifies the proposed sale of 26,530 shares of Common Stock via an exercise of stock options on 06/01/2026. The filing lists 2467555.30 (amount) and a figure 54,666,233 in the securities section. It also discloses prior 10b5-1 sales: 33,830 shares on 03/12/2026 with 2756333.08 (amount).

Insights

Securities Compliance Attorney

Form 144 reports a proposed post-exercise resale and prior 10b5-1 sales; no proceeds allocation is stated.

The notice documents a proposed sale of 26,530 shares tied to an exercise of stock options dated 06/01/2026. It separately lists a prior 10b5-1 sale of 33,830 shares on 03/12/2026.

Filings of this type are administrative disclosures required before resale; the excerpt does not specify who will receive sale proceeds or whether any sale is contingent on other conditions.

Key Figures

Proposed shares: 26,530 shares Associated numeric entry: 2467555.30 Prior 10b5-1 sale shares: 33,830 shares +2 more

5 metrics

Proposed shares 26,530 shares Exercise of stock options on <date>06/01/2026

Associated numeric entry 2467555.30 Listed in the securities section alongside the proposed sale (06/01/2026)

Prior 10b5-1 sale shares 33,830 shares 10b5-1 sale on <date>03/12/2026

Prior 10b5-1 sale amount 2756333.08 Amount listed with 03/12/2026 10b5-1 sale entry

Securities section figure 54,666,233 Numeric entry present in securities information block

Key Terms

10b5-1 Sales, Exercise of Stock Options, Form 144

3 terms

10b5-1 Sales regulatory

"10b5-1 Sales for SIMRAT RANDHAWA 7 Times Square"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Exercise of Stock Options financial

"Common | 06/01/2026 | Exercise of Stock Options"

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	26530	2467555.30	54666233	06/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/01/2026	Exercise of Stock Options	Issuer			26530	06/01/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for SIMRAT RANDHAWA 7 Times Square, 43rd Floor New York NY 10036	Common	03/12/2026	33830	2756333.08

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does DNTH's Form 144 disclose about the 06/01/2026 transaction?

The Form 144 lists a proposed sale of 26,530 shares tied to an exercise of stock options dated 06/01/2026. It records an associated numeric entry of 2467555.30 in the securities section; the filing does not state proceeds recipients.

What 10b5-1 sales are shown for DNTH in the filing?

The filing shows prior 10b5-1 sales by Simrat Randhawa of 33,830 shares on 03/12/2026 with a numeric entry of 2756333.08. It lists this as sales during the past three months without further allocation details.

Does the Form 144 state who will receive proceeds from the proposed sale?

The excerpt does not attach a recipient label to the numeric entries; the securities section shows 2467555.30 near the proposed 26,530-share sale, but the filing text does not explicitly state who receives proceeds or any use-of-proceeds allocation.

Are outstanding share counts included in the DNTH excerpt?

The securities section includes the figure 54,666,233 which appears alongside other securities data. The excerpt does not explicitly label that number as "shares outstanding" or tie it to a specific "as of" date within the visible text.